Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia

Yihan Mei(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianxiang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Experimental Hematology and Oncology
September 6, 2024
10.1186/s40164-024-00560-0
Cited by 7

Related Papers

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
|Journal of Hematology & Oncology|2019|188
Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
|Oncotarget|2016|44
Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells
|Oncotarget|2017|20